Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameMedlive
Stock Code02192
Company Full NameTo be extracted
IndustryHealthcare
Principal Activities我們是中國最大的在線專業醫師平台,自主開發的醫脈通平台為中國製藥及醫療設備公司提供精準數字醫療營銷服務,並為醫師提供專業醫學信息及臨床決策支持,亦為患者提供智能患者管理解決方案及為醫院提供臨床研究數據管理工具。
Listing Date2021-07-15
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國北京朝陽區朝陽北路白家樓甲1號紅莊國際文化保稅創新園
Business Address (Hong Kong)香港勿地臣街1號時代廣場二座31樓
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitewww.medlive.cn
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2980 1333
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism To be extracted
Offer PriceHK$ 27.20 / shares
Offer Price RangeFinal offer price only, no range
Lot Size500 shares
Entry ThresholdHK$ 13,600
Par ValueRMB 1e-05 / shares
Offer Period2021-06-30 to 2021-07-07
Global Offering Shares155,096,000 shares
HK Public Offer Shares (Initial)15,510,000 shares (10.0%)
Public Offer Lots (Initial)31,020lots (Pool A15,510lots,Pool B15,510lots)
International Placing Shares (Initial)139,586,000 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO690,176,000 shares
Greenshoe (Over-allotment Option)Yes
Stabilizing Manager (Greenshoe)To be extracted
Cornerstone Share40.5%
Clawback TiersTo be extracted
Reallocation OptionNo
Total Global Offering SizeHK$ 4,218,611,200

Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 500 HK$ 13,600
2 lots 1,000 HK$ 27,200
3 lots 1,500 HK$ 40,800
4 lots 2,000 HK$ 54,400
5 lots 2,500 HK$ 68,000
6 lots 3,000 HK$ 81,600
7 lots 3,500 HK$ 95,200
8 lots 4,000 HK$ 108,800
9 lots 4,500 HK$ 122,400
10 lots 5,000 HK$ 136,000
12 lots 6,000 HK$ 163,200
14 lots 7,000 HK$ 190,400
16 lots 8,000 HK$ 217,600
18 lots 9,000 HK$ 244,800
20 lots 10,000 HK$ 272,000
30 lots 15,000 HK$ 408,000
40 lots 20,000 HK$ 544,000
50 lots 25,000 HK$ 680,000
60 lots 30,000 HK$ 816,000
70 lots 35,000 HK$ 952,000
80 lots 40,000 HK$ 1,088,000
90 lots 45,000 HK$ 1,224,000
100 lots 50,000 HK$ 1,360,000
120 lots 60,000 HK$ 1,632,000
140 lots 70,000 HK$ 1,904,000
160 lots 80,000 HK$ 2,176,000
180 lots 90,000 HK$ 2,448,000
200 lots 100,000 HK$ 2,720,000
Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
400 lots 200,000 HK$ 5,440,000
600 lots 300,000 HK$ 8,160,000
800 lots 400,000 HK$ 10,880,000
1,000 lots 500,000 HK$ 13,600,000
1,200 lots 600,000 HK$ 16,320,000
1,400 lots 700,000 HK$ 19,040,000
1,600 lots 800,000 HK$ 21,760,000
1,800 lots 900,000 HK$ 24,480,000
2,000 lots 1,000,000 HK$ 27,200,000
4,000 lots 2,000,000 HK$ 54,400,000
6,000 lots 3,000,000 HK$ 81,600,000
8,000 lots 4,000,000 HK$ 108,800,000
10,000 lots 5,000,000 HK$ 136,000,000
12,000 lots 6,000,000 HK$ 163,200,000
14,000 lots 7,000,000 HK$ 190,400,000
15,510 lots 7,755,000 HK$ 210,936,000

Stock Connect Inclusion Analysis

HK Market Cap HK$ 5.81B
Analysis Result Already included in Stock Connect (both)

Valuation & Financials

Market Cap (at Offer Price)HK$ 18,772,787,200
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss Status盈利約人民幣85.2百萬元
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted

Financial Data

Unit: '000 RMB
Income Statement
Item 201820192020
Revenue 83,463121,569213,529
Cost of sales -33,573-44,379-57,293
Gross profit 49,89077,190156,236
Other income and gains, net 99961,543
Selling and distribution expenses -7,080-8,588-20,037
Administrative expenses -26,375-31,391-32,640
Operating profit 16,45937,294105,057
Net finance costs -439-296-209
Profit before tax 16,02036,998104,848
Income tax expense -1,831-5,728-19,651
Profit for the year 14,18931,27085,197
Profit attributable to owners 14,18931,27085,197
Balance Sheet
Item 201820192020
Cash and cash equivalents 16,53038,883147,095
Trade and bills receivables 26,02435,64342,480
Total current assets 56,486101,033208,362
Total current liabilities 30,33944,99164,078
Total equity 34,95866,232151,414
Equity attributable to owners 34,95866,232151,414
Cash Flow Statement
Item 201820192020
Net cash from operating activities 22,09128,203111,048
Net cash from investing activities -3,101-2,42613
Net cash from financing activities -5,846-3,428-2,834
Net increase in cash 13,14422,349108,227
Depreciation of PP&E 1,3071,9442,658
Depreciation of right-of-use assets 3,0482,8882,658
Purchase of PP&E -3,101-2,426-626
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
First Day CloseHK$ 31.0
First Day OpenHK$ 28.9
First Day Change13.97%
First Day Volume115437000.0
First Day Turnover3544610000.0
Use of Proceeds
1、約40%(約1,600.4百萬港元)擬用于在未來三至五年內擴展業務; 2、約30%(約1,200.3百萬港元)擬用于在未來三至五年內投資技術及提高研發能力; 3、約20%(約800.2百萬港元)擬用于有精心挑選戰略投資或收購機會; 4、約10%(約400.1百萬港元)擬用作一般補充營運資金及其他一般企業用途。

Underwriting Syndicate

Joint Sponsors (2)
GOLDMAN SACHS (ASIA) L.L.C. CE ACC536 海通国际资本有限公司 CE ADQ859
Overall Coordinators (3)
GOLDMAN SACHS (ASIA) L.L.C. CE ACC536 海通国际证券有限公司 CE AAF806 中国国际金融香港证券有限公司 CE AEN894
Joint Bookrunners (3)
GOLDMAN SACHS (ASIA) L.L.C. CE ACC536 海通国际证券有限公司 CE AAF806 中国国际金融香港证券有限公司 CE AEN894
Joint Lead Managers (3)
GOLDMAN SACHS (ASIA) L.L.C. CE ACC536 海通国际证券有限公司 CE AAF806 中国国际金融香港证券有限公司 CE AEN894

Cornerstone Investors

#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 Fidelity International 310,501,600 HKD — 7.36% — 6 months 2022-01-15
2 Fidelity Management & Research (Hong Kong) Limited 310,501,600 HKD — 7.36% — 6 months 2022-01-15
3 GIC Private Limited 310,501,600 HKD — 7.36% — 6 months 2022-01-15
4 Matthews Asia Funds 155,244,000 HKD — 3.68% — 6 months 2022-01-15
5 OrbiMed Funds 155,244,000 HKD — 3.68% — 6 months 2022-01-15
6 Springhill Master Fund Limited 155,244,000 HKD — 3.68% — 6 months 2022-01-15
7 Tencent Mobility Limited 310,501,600 HKD — 7.36% — 6 months 2022-01-15

Directors & Management

PositionChinese nameEnglish Name
Chairman田立平—
Company Secretary楊艷玲、司徒嘉怡—
No director data available.

Major Shareholders

Major Shareholders & HoldingsTiantian及M3各自持有緊隨全球發售完成後已發行股本約38.8%;Tiantian由田立平、田立新及田立軍分別持有48%、37%及15%股權,M3由Sony Group Corporation持有約33.95%股權。
About this page

This page shows Medlive (02192) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect